Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0334907 BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY
The invention relates to bicyclic heterocycle compounds of formula (I): ##STR00001## or tautomeric or stereochemically isomeric forms, N-oxides, pharmaceutically...
2017/0334906 NEW COMPOUNDS AS NIK INHIBITORS
The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of ...
2017/0334905 NOVEL COMPOSITIONS, USES AND METHODS FOR MAKING THEM
Generally, the present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce...
2017/0334904 PYRIMIDO[4,5-B]INDOLE DERIVATIVES AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS
Pyrimido[4,5-b]indole derivatives are provided. These compounds are useful to expand hematopoietic stem cell populations, particularly, human hematopoietic...
2017/0334903 METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal...
2017/0334902 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically...
2017/0334901 QUINOLINONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
The invention provides novel quinolinone-carboxamide 5-HT.sub.4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising...
2017/0334900 NEW PYRAZOLE DERIVATIVES AS NIK INHIBITORS
The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of ...
2017/0334899 AMINO-SUBSTITUTED ISOTHIAZOLES
The present invention relates to amino-substituted isothiazoles of general formula (I): in which A, R1 and R2 are as defined in the claims, to methods of...
2017/0334898 NOVEL 4-METHYL-DIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, M and X are as described...
2017/0334897 Liver X Receptor (LXR) Modulators For The Treatment Of Dermal Diseases, Disorders And Conditions
Described herein are liver X receptor (LXR) modulators and methods of milizing LXR modulators in the treatment of dermal diseasess, disorders or conditions....
2017/0334896 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof
The invention provides a compound as shown by Formula I having an enzyme activity which can inhibit endocannabinoid hydrolases NAAA and/or FAAH, or a...
2017/0334895 DOPAMINE D3 RECEPTOR ANTAGONIST COMPOUNDS
The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical...
2017/0334894 Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof
The present invention provides compounds of Formula I: ##STR00001## and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these...
2017/0334893 Isoxazole Analogs as FXR Agonists and Methods of Use Thereof
The present invention provides compounds of Formula I: ##STR00001## pharmaceutical compositions comprising these compounds and methods of using these compounds...
2017/0334892 LKB1-AMPK ACTIVATORS FOR THERAPEUTIC USE IN POLYCYSTIC KIDNEY DISEASE
Compounds are provided for use in treating polycystic kidney disease (PKD) and in associated methods that include a method of modulating (e.g., activating)...
2017/0334891 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions...
2017/0334890 SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION
Methods for improving mitochondrial function, decreasing iron accumulation, and/or decreasing oxidative stress by exposing cells or treating a subject to...
2017/0334889 COMPOUNDS AND METHODS FOR ACTIVATING THE APOPTOTIC ARM OF THE UNFOLDED PROTEIN RESPONSE
N-substituted sulfonylphenyl-5-nitrofuranyl-2-carboxamide derived compounds, which selectively activate the apoptotic, but not the adaptive arm, of the...
2017/0334888 SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS
Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose: N-acylsphingosine glucosyltransferase. Also disclosed are novel...
2017/0334887 Imidazole-Based Antimicrobial Agents
The present invention relates to novel therapeutic agents suitable for use in the treatment of mammalian disease and in particular to novel therapeutic agents...
2017/0334886 N-SUBSTITUTED 4-AMINOQUINAZOLINE DERIVATIVES AND METHODS OF USE
The present invention provides kinase inhibitor analogs with improved properties, such as improved efficacy, pharmacokinetics, safety, and specificity. In some...
2017/0334885 PYRAZOLE COMPOUNDS
This invention relates to pyrazole compounds or pharmaceutically acceptable salts thereof. Compounds of this invention are inhibitors of methionine...
2017/0334884 PROCESS FOR THE PURIFICATION OF THE AXL TYROSINE RECEPTOR KINASE INHIBITOR "R428"
A process for purifying 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine-3-yl)-N.sup.3-(7-- ...
2017/0334883 THERAPEUTIC COMPOUNDS AND USES THEREOF
The present invention relates to methods for treating PCAF mediated disorders using a compound of formula (I) or a pharmaceutically acceptable salt thereof: ...
2017/0334882 HEPATITIS B ANTIVIRAL AGENTS
The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to...
2017/0334881 NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES
The invention provides certain nicotine salts, co-crystals, and salt co-crystals and provides novel polymorphic forms of certain nicotine salts. In particular,...
2017/0334880 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL DISEASES
The present invention relates to novel compounds of formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein the integers are as defined in...
2017/0334879 HISTONE DEMETHYLASE INHIBITORS
The present invention relates generally to compositions and methods for treating cancer and neoplastic diseases. Provided herein are substituted ...
2017/0334878 SYNTHESIS OF 6-ARYL-4-AMINOPICOLINATES AND 2-ARYL-6-AMINOPYRIMIDINE-4-CARBOXYLATES BY DIRECT SUZUKI COUPLING
Improved methods of synthesizing 6-aryl-4-aminopicolinates, such as arylalky and alkyl ...
2017/0334877 REVAPRAZAN HYDROCHLORIDE POLYMORPHS AND PREPARATION METHOD THEREFOR
Provided are revaprazan hydrochloride polymorphs and a preparation method thereof. The method comprises a step of dissolving revaprazan hydrochloride in...
2017/0334876 NOVEL CYCLIC COMPOUND AND OPTICAL MATERIAL COMPOSITION INCLUDING SAME
One embodiment of the present invention can provide an optical material composition that includes a cyclic compound that is represented by formula (1) and an...
2017/0334875 METHOD FOR THE PRODUCTION OF VITAMIN E WITH A HIGH PURITY, VITAMIN E PRODUCED BY SAID METHOD, AND A COMPOSITION...
A method is provided for manufacturing high-purity vitamin E compounds by selectively separating vitamin E compounds such as tocotrienols and tocopherols from...
2017/0334874 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME
Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as...
2017/0334873 KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE
Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A,...
2017/0334872 SEMI-SYNTHESIS PROCEDURES
Provided herein are improved processes for convening C7-amino-substituted tetracylines to C7-fluoro-substituted tetracyclines as well as intermediates produced...
2017/0334871 Thymoquinone Derivatives for Treatment of Cancer
The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer. ...
2017/0334870 PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE
Pharmaceutical compositions of the invention include substituted riluzole prodrugs useful for the treatment of cancers including melanoma, breast cancer, brain...
2017/0334869 NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER
The present disclosure relates to benzamide compounds, prodrugs of the compounds, pharmaceutical compositions containing the compounds and/or the prodrugs and...
2017/0334868 COMPOSITIONS AND METHODS OF TREATMENT WITH PRODRUGS OF TIZOXANIDE, AN ANALOGUE OR SALT THEREOF
Prodrugs of tizoxanide, an analogue or salt thereof are disclosed. The prodrugs have an ester moiety comprising an amino acid moiety, and increase the...
2017/0334867 PROTEASE INHIBITORS
Compounds of the formula II: ##STR00001## wherein R.sup.1 and R.sup.2 are independently H, F or CH.sub.3 ; or R.sup.1 forms an ethynyl bond and R.sup.2 is H or...
2017/0334866 CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS
Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-.gamma.-lyase (CSE). Also described herein...
2017/0334865 DDR2 INHIBITORS AND METHODS OF USING
Compounds that inhibit activation of Discoidin Domain Receptor 2 (DDR2) and methods of using the compounds to inhibit DDR2 activation, inhibit migration of...
2017/0334864 3,5-DIAMINO-6-CHLORO-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-PENTAHYDROXYHEXYL)AMIN- O)ETHOXY)PHENYL)BUTYL)...
The present invention relates to the compound of the formula: ##STR00001## or pharmaceutically acceptable salts thereof, as well as compositions containing the...
2017/0334863 Cdc42 INHIBITOR AND USES THEREOF
Compounds which inhibit the small G protein Rho GTPase cell division cycle protein Cdc42 are provided. Morphological analyses of filopodia, western blots of...
2017/0334862 IMIDAZOLE DERIVATIVES AS PRODRUGS OF DICLOFENAC
The present invention relates to a compound of formula (I): ##STR00001## wherein R.sub.1 is R.sub.3-IPU and R.sub.2 is the acyloxy residue of diclofenac, and...
2017/0334861 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present...
2017/0334860 NOVEL POLYMORPHS OF IVACAFTOR, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF
The present invention relates to novel polymorphic forms of ivacaftor, process for its preparation and pharmaceutical compositions comprising the same.
2017/0334859 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.
2017/0334858 PROCESS FOR THE PREPARATION OF INTERMEDIATE OF DOLUTEGRAVIR
The present invention provides a novel processes for preparation of methyl 3-(benzyloxy)-5-(2,4-difluorobenzylcarbamoyl)-4-oxo-1-(2-oxoethyl)- ...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.